Literature DB >> 23417715

Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.

Nana Aburjania1, Alexander M Truskinovsky, Michael J Overman, Emil Lou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23417715     DOI： 10.1007/s12029-013-9479-5

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  16 in total

Review 1.  The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directions.

Authors:  Fiona Chionh; Gillian Mitchell; Geoffrey J Lindeman; Michael Friedlander; Clare L Scott
Journal:  Asia Pac J Clin Oncol       Date:  2011-09       Impact factor: 2.601

Review 2.  Familial pancreatic cancer: a review.

Authors:  H T Lynch; T Smyrk; S E Kern; R H Hruban; C J Lightdale; S J Lemon; J F Lynch; L R Fusaro; R M Fusaro; P Ghadirian
Journal:  Semin Oncol       Date:  1996-04       Impact factor: 4.929

3.  Update on PARP1 inhibitors in ovarian cancer.

Authors:  C Sessa
Journal:  Ann Oncol       Date:  2011-12       Impact factor: 32.976

4.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

5.  Tumors of ampulla of Vater: A case series and review of chemotherapy options.

Authors:  Adriana Romiti; Viola Barucca; Angelo Zullo; Ida Sarcina; Roberta Di Rocco; Chiara D'Antonio; Marco Latorre; Paolo Marchetti
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

6.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Jordan M Winter; Kurtis A Campbell; Ralph H Hruban; David Chang; Charles J Yeo
Journal:  Surgery       Date:  2006-08-28       Impact factor: 3.982

Review 7.  Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.

Authors:  J H Lee; R Whittington; N N Williams; M F Berry; D J Vaughn; D G Haller; E F Rosato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

8.  BRCA2 germline mutations in familial pancreatic carcinoma.

Authors:  Stephan A Hahn; Bill Greenhalf; Ian Ellis; Mercedes Sina-Frey; Harald Rieder; Birgit Korte; Berthold Gerdes; Ralf Kress; Andreas Ziegler; John A Raeburn; Donata Campra; Robert Grützmann; Helga Rehder; Matthias Rothmund; Wolff Schmiegel; John P Neoptolemos; Detlef K Bartsch
Journal:  J Natl Cancer Inst       Date:  2003-02-05       Impact factor: 13.506

9.  BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.

Authors:  Cristina R Ferrone; Douglas A Levine; Laura H Tang; Peter J Allen; William Jarnagin; Murray F Brennan; Kenneth Offit; Mark E Robson
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

10.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Authors:  Peter C Fong; David S Boss; Timothy A Yap; Andrew Tutt; Peijun Wu; Marja Mergui-Roelvink; Peter Mortimer; Helen Swaisland; Alan Lau; Mark J O'Connor; Alan Ashworth; James Carmichael; Stan B Kaye; Jan H M Schellens; Johann S de Bono
Journal:  N Engl J Med       Date:  2009-06-24       Impact factor: 91.245
View more
  2 in total

1.  Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas.

Authors:  Pedro Pinto; Ana Peixoto; Catarina Santos; Patrícia Rocha; Carla Pinto; Manuela Pinheiro; Luís Leça; Ana Teresa Martins; Verónica Ferreira; Carla Bartosch; Manuel R Teixeira
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

2.  Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predisposition.

Authors:  Simona Agata; Silvia Tognazzo; Elisa Alducci; Laura Matricardi; Lidia Moserle; Daniela Barana; Marco Montagna
Journal:  Sci Rep       Date:  2020-08-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.